These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis. Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH. J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124 [Abstract] [Full Text] [Related]
6. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia. Rosana Y, Yasmon A, Lestari DC. J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039 [Abstract] [Full Text] [Related]
7. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans. Khajeh E, Hosseini Shokouh SJ, Rajabibazl M, Roudbary M, Rafiei S, Aslani P, Farahnejad Z. Br J Biomed Sci; 2016 Sep; 73(1):44-8. PubMed ID: 27182677 [Abstract] [Full Text] [Related]
8. Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression. Kofla G, Ruhnke M. J Microbiol Methods; 2007 Jan; 68(1):178-83. PubMed ID: 16945439 [Abstract] [Full Text] [Related]
10. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712 [Abstract] [Full Text] [Related]
11. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates. Jin L, Cao Z, Wang Q, Wang Y, Wang X, Chen H, Wang H. BMC Infect Dis; 2018 Apr 10; 18(1):162. PubMed ID: 29631565 [Abstract] [Full Text] [Related]
12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D, Coste AT. Antimicrob Agents Chemother; 2016 Jan 10; 60(1):229-38. PubMed ID: 26482310 [Abstract] [Full Text] [Related]
15. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Lopez-Ribot JL, McAtee RK, Lee LN, Kirkpatrick WR, White TC, Sanglard D, Patterson TF. Antimicrob Agents Chemother; 1998 Nov 10; 42(11):2932-7. PubMed ID: 9797228 [Abstract] [Full Text] [Related]
19. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. Yu LH, Wei X, Ma M, Chen XJ, Xu SB. Antimicrob Agents Chemother; 2012 Feb 10; 56(2):770-5. PubMed ID: 22106223 [Abstract] [Full Text] [Related]
20. Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole-Resistant Clinical Isolates of Candida albicans, Biological Activity and ERG11, CDR1, and CDR2 Gene Expression. Hassanpour P, Hamishehkar H, Bahari Baroughi B, Baradaran B, Sandoghchian Shotorbani S, Mohammadi M, Shomali N, Aghebati-Maleki L, Nami S. Assay Drug Dev Technol; 2021 Oct 10; 19(7):453-462. PubMed ID: 34435891 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]